SCHEMBL3850109

SCHEMBL3850109

CN1CCN(c2ncnc3ccc(-c4cn[nH]c4)cc23)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 15/20 0.65
CYP1A2 P05177 14/20 0.65
ALDH1A1 P00352 12/20 0.65
CLK4 Q9HAZ1 11/20 0.65
LMNA P02545 8/20 0.65
CYP2D6 P10635 8/20 0.65
MAPK1 P28482 7/20 0.65
MEN1 O00255 7/20 0.65
KMT2A Q03164 7/20 0.65
ALOX15 P16050 1/20 0.65
HIF1A Q16665 11/20 0.64
USP2 O75604 8/20 0.64
CYP2C19 P33261 7/20 0.64
TSHR P16473 5/20 0.60
KDM4E B2RXH2 3/20 0.59
HPGD P15428 3/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
HSD17B10 Q99714 2/20 0.58
HTT P42858 1/20 0.58
AKT1 P31749 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3851639 0.85 ACHE (0.54) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3867694 0.85 AKT1 (0.58) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3856706 0.84 AKT1 (0.53) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL5853435 0.84 ACHE (0.56) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL4714577 0.84 CYP1A2 (0.51) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL30734227 0.83 ACHE (0.57) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3854046 0.83 AKT1 (0.56) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL3848425 0.83 ENPP1 (0.52) CYP3A4CYP1A2ALDH1A1CLK4LMNA
Hydrochloric Acid SCHEMBL3849363 0.83 CYP1A2 (0.50) CYP3A4CYP1A2ALDH1A1CLK4LMNA
SCHEMBL5853346 0.82 AKT1 (0.54) CYP3A4CYP1A2ALDH1A1CLK4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed